Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416611![]() (4-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416615![]() (4-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416551![]() (US10307425, Example 17 | US10632122, Example 17) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416560![]() (US10307425, Example 26 | US10632122, Example 26) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416572![]() (3-(2-cyclopropoxyquinolin-6-yl)-1-(piperidin-4-ylm...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416558![]() (US10307425, Example 24 | US10632122, Example 24) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid PDB UniChem | PDB Article US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416565![]() (3-(4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416552![]() (US10307425, Example 18 | US10632122, Example 18) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416553![]() (US10307425, Example 19 | US10632122, Example 19) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416613![]() (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416577![]() (1-(piperidin-4-ylmethyl)-3-(2-(2,2,2-trifluoroetho...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416619![]() (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416538![]() (US10307425, Example 4 | US10632122, Example 4) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416537![]() (US10307425, Example 3 | US10632122, Example 3) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416570![]() (3-(4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[3...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416569![]() (1-isobutyl-3-(6-(2-methoxyethoxy)naphthalen-2-yl)-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416554![]() (US10307425, Example 20 | US10632122, Example 20) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416556![]() (US10307425, Example 22 | US10632122, Example 22) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416627![]() (3-(6-(difluoromethoxy)naphthalen-2-yl)-1-(piperidi...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389717![]() (CHEMBL2070085 | US10307425, Example 107 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416559![]() (US10307425, Example 25 | US10632122, Example 25) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid PDB UniChem | PDB Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416637![]() (3-(2-ethoxyquinolin-6-yl)-1-isopropyl-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416576![]() (1-isobutyl-3-(2-(2,2,2-trifluoroethoxy)quinolin-6-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416541![]() (US10307425, Example 7 | US10632122, Example 7) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389718![]() (CHEMBL2070086 | US10307425, Example 108 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416550![]() (US10307425, Example 16 | US10632122, Example 16) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416573![]() (1-(azetidin-3-ylmethyl)-3-(2-cyclopropoxyquinolin-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416555![]() (US10307425, Example 21 | US10632122, Example 21) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416535![]() (US10307425, Example 1 | US10632122, Example 1) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416633![]() (4-((4-amino-3-(6-(difluoromethoxy)naphthalen-2-yl)...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416630![]() (3-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416563![]() (3-(6-cyclobutoxynaphthalen-2-yl)-1-((tetrahydro-2H...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389719![]() (CHEMBL2070087 | US10307425, Example 109 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416607![]() (4-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416574![]() (3-(2-cyclopropoxyquinolin-6-yl)-1-((1-methylazetid...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416626![]() (3-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416582![]() (3-(6-ethoxynaphthalen-2-yl)-1-((3-methyloxetan-3-y...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416598![]() ((3-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416648![]() (1-((6-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrim...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416634![]() (3-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389720![]() (CHEMBL2070088 | US10307425, Example 110 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416588![]() (1-(4-amino-5-(2-cyclopropoxyquinolin-6-yl)-7H-pyrr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416557![]() (US10307425, Example 23 | US10632122, Example 23) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389684![]() (CHEMBL2070051 | US10307425, Example 119 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM439387![]() (US10632122, Example 83) | PDB UniProtKB/TrEMBL GoogleScholar | UniChem | Article US Patent | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416597![]() ((3-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-py...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416624![]() (3-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416571![]() (3-(2-(2-methoxyethoxy)quinolin-6-yl)-1-neopentyl-1...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416617![]() (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416568![]() (1-isobutyl-3-(6-(oxetan-3-yloxy)naphthalen-2-yl)-1...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416544![]() (US10307425, Example 10 | US10632122, Example 10) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389750![]() (CHEMBL2070089 | US10307425, Example 111 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389710![]() (CHEMBL2070077 | US10307425, Example 112 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM50389711![]() (CHEMBL2070078 | US10307425, Example 113 | US106321...) | PDB UniProtKB/TrEMBL GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | Article US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416539![]() (US10307425, Example 5 | US10632122, Example 5) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416612![]() (4-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416562![]() (3-(6-(cyclopropylmethoxy)naphthalen-2-yl)-1-((tetr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416636![]() (3-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416623![]() (3-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416625![]() (4-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416540![]() (US10307425, Example 6 | US10632122, Example 6) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416566![]() (1-(6-(4-amino-1-isobutyl-1H-pyrazolo[3,4-d]pyrimid...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416567![]() (2-(6-(4-amino-1-isobutyl-1H-pyrazolo[3,4-d]pyrimid...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416543![]() (US10307425, Example 9 | US10632122, Example 9) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416590![]() (1-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416549![]() (US10307425, Example 15 | US10632122, Example 15) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416647![]() (1-isopropyl-3-(6-(oxetan-3-yloxy)naphthalen-2-yl)-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416649![]() (2-((6-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrim...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416610![]() (3-(6-cyclopropoxynaphthalen-2-yl)-1-(2-fluoro-2-me...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416628![]() (3-(6-(difluoromethoxy)naphthalen-2-yl)-1-((1-methy...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416631![]() (4-((4-amino-3-(6-(difluoromethoxy)naphthalen-2-yl)...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416629![]() (3-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 7.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416575![]() (3-(2-(2-methoxyethoxy)quinolin-6-yl)-1-((1-methylp...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416592![]() (1-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 8.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416591![]() (1-(4-amino-5-(6-cyclopropoxynaphthalen-2-yl)-7H-py...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 9.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416601![]() (US10307425, Example 68 | US10632122, Example 68 | ...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 9.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416645![]() (1-(6-ethoxynaphthalen-2-yl)-3-(piperidin-4-ylmethy...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416546![]() (US10307425, Example 12 | US10632122, Example 12) | PDB UniProtKB/TrEMBL GoogleScholar | UniChem | Article US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416580![]() (3-(7-ethoxynaphthalen-2-yl)-1-isobutyl-1H-pyrazolo...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid PDB UniChem | PDB Article US Patent | n/a | n/a | 10.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416593![]() (1-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 12.7 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416596![]() (4-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 12.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416594![]() (1-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416545![]() (US10307425, Example 11 | US10632122, Example 11) | PDB UniProtKB/TrEMBL GoogleScholar | UniChem | Article US Patent | n/a | n/a | 15.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416584![]() (2-(4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-py...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416536![]() (US10307425, Example 2 | US10632122, Example 2) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 17.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416635![]() (4-((4-amino-3-(6-(difluoromethoxy)naphthalen-2-yl)...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 18.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM439378![]() (US10632122, Example 75) | PDB UniProtKB/TrEMBL GoogleScholar | UniChem | Article US Patent | n/a | n/a | 18.3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416579![]() (1-(4-amino-3-(2-(2,2,2-trifluoroethoxy)quinolin-6-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 18.3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416646![]() (1-(6-ethoxynaphthalen-2-yl)-3-((1-methylpiperidin-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 18.6 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416581![]() (3-(7-ethoxynaphthalen-2-yl)-1-(piperidin-4-ylmethy...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid PDB UniChem | PDB Article US Patent | n/a | n/a | 19.1 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416595![]() (4-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 19.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416609![]() (3-(4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-py...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 19.4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416618![]() (4-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416561![]() (3-(2-methoxyquinolin-6-yl)-1-((tetrahydro-2H-pyran...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 21.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416613![]() (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 23.1 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416603![]() (4-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 23.3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416548![]() (US10307425, Example 14 | US10632122, Example 14) | PDB UniProtKB/TrEMBL GoogleScholar | UniChem | Article US Patent | n/a | n/a | 24.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416564![]() (3-(6-(oxetan-3-yloxy)naphthalen-2-yl)-1-((tetrahyd...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 35.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416632![]() (4-((4-amino-3-(6-(difluoromethoxy)naphthalen-2-yl)...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 35.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416583![]() (2-(4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 42.9 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416602![]() (US10307425, Example 69 | US10632122, Example 69 | ...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 43.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416547![]() (US10307425, Example 13 | US10632122, Example 13) | PDB UniProtKB/TrEMBL GoogleScholar | UniChem | Article US Patent | n/a | n/a | 46.3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416586![]() (2-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 47.3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416605![]() (US10307425, Example 72 | US10632122, Example 72 | ...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 49.6 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416604![]() (4-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 59.3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416589![]() (4-(4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyra...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 70.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416606![]() (2-((6-(4-amino-1-((1-methylpiperidin-4-yl)methyl)-...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 73.8 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416585![]() (2-((4-amino-3-(6-(methoxymethyl)naphthalen-2-yl)-1...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 84.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416542![]() (US10307425, Example 8 | US10632122, Example 8) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 94.9 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416620![]() (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 103 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416621![]() (2-(6-(4-amino-1-(2-hydroxy-2-methylpropyl)-1H-pyra...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 112 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416600![]() (3-(2-cyclopropoxyquinolin-6-yl)-1-(2-methoxy-2-met...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416578![]() (2-(3-(4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-p...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416622![]() (US10307425, Example 89 | US10632122, Example 89 | ...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416587![]() (1-(3-(6-cyclopropoxynaphthalen-2-yl)-1H-pyrrolo[3,...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calmodulin-domain protein kinase 1 (Toxoplasma gondii) | BDBM416599![]() (3-(6-cyclopropoxynaphthalen-2-yl)-1-(2-methoxy-2-m...) | PDB UniProtKB/TrEMBL GoogleScholar | PC cid PC sid UniChem | Article US Patent | n/a | n/a | 1.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10632122 (2020) Article DOI: null | |||||||||||
More data for this Ligand-Target Pair |